Retatrutide

Retatrutide

Catalog strength: 10mg/2ml

Research Overview

Retatrutide is a triple agonist peptide studied for its activity at the GLP-1, GIP, and glucagon receptors. Research models have examined its role in energy metabolism, appetite-regulation pathways, and glucose homeostasis, with particular interest in how combined incretin and glucagon receptor activation may influence body-composition outcomes in preclinical studies.

Mechanistically, research has focused on: Incretin Receptor Activity (combined GLP-1 and GIP receptor agonism has been studied for effects on insulin secretion and gastric emptying in experimental systems), and Glucagon Receptor Engagement (concurrent glucagon receptor activity is an area of investigation for its potential contribution to energy expenditure pathways).

CAS number: 2381089-83-2

Molar mass: 4731.35 g/mol

RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY USE.

This product is offered strictly as a laboratory research material for qualified researchers and educational or analytical use. It is not a drug, food, dietary supplement, cosmetic, medical device, or consumer product. It is not intended for ingestion, injection, inhalation, topical application, compounding, prescribing, dispensing, administration, or any other use in humans or animals.

This product has not been approved by the U.S. Food and Drug Administration. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. Statements describing mechanisms, pathways, observations, or potential benefits summarize the research context presented in the source catalog and do not constitute medical advice, therapeutic claims, instructions for use, or evidence of safety or efficacy in humans.

The purchaser is solely responsible for verifying that acquisition, possession, handling, storage, research, transfer, and disposal comply with all applicable federal, state, and local laws, institutional requirements, and laboratory safety standards. Sale may be restricted to appropriately qualified research entities. By purchasing, the purchaser represents that the material will be used only for lawful, non-clinical research and will not be resold or supplied for human or veterinary administration.